Where Will Netflix Stock Be in 3 Years?
2026-09-02 17:13
•Justin Pope •The Motley Fool
•• • Axe Cap view
Netflix’s Next Act: Betting Beyond Subscribers
Netflix’s shift to diverse income streams could reshape its growth story and valuation.
Netflix is no longer just about adding subscribers. The drive into ad-supported plans, live sports, podcasts, and gaming signals a pivot from pure volume growth to squeezing more value out of existing customers. For investors watching from South Africa, this diversification means the stock could turn from a boom-or-bust growth play into a steadier, multi-revenue-stream business. The valuation, under 23 times projected 2026 earnings, seems fair for a company expected to grow earnings by 22% annually. On the JSE, companies like Naspers and Prosus, which hold stakes in similar digital platforms, could indirectly benefit if Netflix’s strategy succeeds globally and boosts their underlying value. But the risks are real; if Netflix’s new ventures fail to engage enough users or ad revenue disappoints, the stock might stall. Also, a stronger rand against the dollar (USD/ZAR) could pressure dollar-denominated earnings when translated back home, affecting South African investors’ returns. this is just our opinion and not financial advice
Watch Netflix as a long-term hold if you’re comfortable with tech risk and exposure to the USD. For direct South African plays, Naspers and Prosus remain reasonable proxies, but trim exposure if the rand strengthens significantly or subscriber growth disappoints.
- NFLX
- Naspers
- Prosus
- USD/ZAR
- Netflix’s diversification efforts underperform
- Rand appreciation hurts USD earnings translation
6/10
Netflix is transitioning from a subscriber-growth focused company to one leveraging multiple monetization strategies including ad-supported subscriptions, live sports, podcasts, and gaming. With a valuation of less than 23x 2026 earnings and expected 22% annual earnings growth, the stock could potentially double over the next three years, offering attractive returns for patient investors.
Our take is based on reporting first published by The Motley Fool.